16:02 Dec 20
GlaxoSmithKline Pharmaceuticals Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
GlaxoSmithKline Pharmaceuticals Ltd.
Industry Pharmaceuticals
16:02 Dec 20
Quality
66/100
High Financial Strength
Valuation
14/100
Expensive Valuation
Technical
48/100
Technically Neutral
Strength
4
Weakness
6
Opportunity
1
Threats
0
1.93 %
Dividend Yield
38.56K
Market Cap (Cr)
37.24
RSI
75.00 %
Promoter Holding
17.20 %
Net Profit Margin
| Client | Date | Avg Price | Qty | Value(Cr) | Action |
|---|
Download Our App On:
